EP Patent

EP4637753A2 — Phenyl-pyrazole carboxamide compounds

Assigned to Acrivon Therapeutics Inc · Expires 2025-10-29 · 1y expired

What this patent protects

Phenyl -pyrazole carboxamide compounds of formula I (I) for use in methods of inhibiting Myt1 kinase.

USPTO Abstract

Phenyl -pyrazole carboxamide compounds of formula I (I) for use in methods of inhibiting Myt1 kinase.

Drugs covered by this patent

Patent Metadata

Patent number: EP4637753A2
Jurisdiction: EP
Classification: —
Expires: 2025-10-29
Drug substance claim: No
Drug product claim: No
Assignee: Acrivon Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.